COCP insider transaction filings
Cocrystal Pharma, Inc. — 22 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-06. Screen COCP transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-06 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 10,000 @ $0.98 | EDGAR |
| 2026-08-05 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 75,000 @ $0.94 | EDGAR |
| 2026-06-03 | 4 | SAPIRSTEIN JAMES — Chief Executive Officer | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 20,000 @ $1.00 | EDGAR |
| 2026-02-09 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 50,000 @ $0.95 | EDGAR |
| 2026-01-13 | 4 | Kornberg Roger D. — Director | Grant/award (A): 24,615 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Lee Sam — President and Co-CEO | Grant/award (A): 49,229 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Martin James Joseph — Co-CEO and CFO | Grant/award (A): 49,229 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Grant/award (A): 24,615 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Japour Anthony J — Director | Grant/award (A): 16,410 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Rubin Steven D — Director | Grant/award (A): 16,410 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | PFENNIGER RICHARD C JR — Director | Grant/award (A): 16,410 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Hassan Fred — Director | Grant/award (A): 16,410 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 50,000 @ $0.95 | EDGAR |
| 2025-12-31 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 20,000 @ $0.97 | EDGAR |
| 2025-12-29 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 25,000 @ $0.97 · Purchase (P): 40,000 @ $0.97 | EDGAR |
| 2025-11-28 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 1,500 @ $1 · Purchase (P): 2,500 @ $0.99 | EDGAR |
| 2025-11-25 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Purchase (P): 20,000 @ $0.94 | EDGAR |
| 2025-10-30 | 4 | FROST PHILLIP MD ET AL — Director, 10% owner | Grant/award (A): 359,713 @ $1.39 · Grant/award (A): 719,426 (derivative) @ $1.39 | EDGAR |
| 2025-10-30 | 4 | Martin James Joseph — Co-CEO and CFO | Grant/award (A): 3,598 @ $1.39 · Grant/award (A): 7,196 (derivative) @ $1.39 | EDGAR |
| 2025-10-30 | 4 | PFENNIGER RICHARD C JR — Director | Grant/award (A): 20,000 · Grant/award (A): 40,000 (derivative) @ $1.39 | EDGAR |
| 2025-10-30 | 4 | Hassan Fred — Director | Grant/award (A): 359,713 @ $1.39 · Grant/award (A): 719,426 (derivative) @ $1.39 | EDGAR |
Recent 8-K events — Cocrystal Pharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=COCP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →